Myron Wentz
Founder bei USANA HEALTH SCIENCES, INC.
Vermögen: 382 Mio $ am 31.03.2024
Aktive Positionen von Myron Wentz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
USANA HEALTH SCIENCES, INC. | Director/Board Member | 01.05.2020 | - |
Founder | 01.09.1992 | - | |
Chief Executive Officer | 01.09.1992 | 23.07.2008 | |
Chairman | 01.09.1992 | - |
Karriereverlauf von Myron Wentz
Ehemalige bekannte Positionen von Myron Wentz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IMMUNOSYN CORP | Director/Board Member | 14.03.2008 | 20.03.2009 |
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Chairman | 01.01.1974 | 01.01.1998 |
Founder | 01.01.1974 | 01.01.1998 | |
Sanoviv SA de CV | Founder | 01.01.1998 | - |
Ausbildung von Myron Wentz
University of Utah | Doctorate Degree |
North Central College | Undergraduate Degree |
University of North Dakota | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Mexiko | 2 |
Operativ
Founder | 3 |
Director/Board Member | 2 |
Chairman | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
USANA HEALTH SCIENCES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Health Technology |
Immunosyn Corp.
Immunosyn Corp. BiotechnologyHealth Technology Immunosyn Corp. is a development stage company. It engages in the marketing, distribution, and sale of a biopharmaceutical drug product SF-1019, which is used for the treatment of various diseases and pathological conditions, including chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. The company was founded in August 2006 and is headquartered in San Diego, CA. | Health Technology |
Sanoviv SA de CV |
- Börse
- Insiders
- Myron Wentz
- Erfahrung